Home
Daniel Karlin, Chief Medical Officer: Definium Therapeutics DFTX Sell · Filed 09/29
Trade details
- Type
- Insider sale
- Amount
- $396,894.21
- Shares · price
- 10,853 sh · $36.57 a share
- Held after
- 792,846 sh
- Trade date
- 26/09/25
- Filed
- 26/09/29
- Days to filing
- 4 days
Sold 1.4% of holdings
- Share of holding sold
- 1.4%
Definium Therapeutics trades, last 26 weeks
What else happened in Definium Therapeutics around then
Filed or reported within 30 days of the trade day · 08/26~10/25Daniel Karlin's recent trades
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$398.6K
10,853 sh
$398.6K
Filed 09/25
Traded 09/25
- Daniel Karlin
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$451.9K
10,035 sh
$451.9K
Filed 06/26
Traded 06/25
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$422.8K
10,035 sh
$422.8K
Filed 06/25
Traded 06/25
- Daniel Karlin
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$148.1K
8,018 sh
$148.1K
Filed 03/26
Traded 03/25
- Daniel Karlin
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$148.1K
8,018 sh
$148.1K
Filed 03/25
Traded 03/25